default author photo

Lisa Pickering

Royal Marsden NHS Foundation Trust - Renal and Skin Units

London

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

110

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Determinants of Anti-PD1 Response and Resistance in Clear Cell Renal Cell Carcinoma

Number of pages: 64 Posted: 26 Mar 2021
The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Retroviral Immunology, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Cancer Dynamics Laboratory, University College London - Cancer Immunology Unit, The Francis Crick Institute, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Francis Crick Institute - Cancer Dynamics Laboratory, Francis Crick Institute - Cancer Dynamics Laboratory, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Francis Crick Institute - Retroviral Immunology, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London - Cancer Immunology Unit, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Biocruces Bizkaia Health Research Institute - Department of Pathology, Guy's and St Thomas' NHS Foundation Trust - Department of Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, University College London Cancer Institute - Cancer Research UK Lung Cancer Centre of Excellence, University College London Hospital - Department of Cellular Pathology, University College London Hospital - Department of Cellular Pathology, Royal Marsden NHS Foundation Trust - Renal and Skin Units, Royal Marsden NHS Foundation Trust - Renal and Skin Units, University College London - Cancer Immunology Unit, Peter MacCallum Cancer Centre - Division of Research, University College London Hospital - Department of Cellular Pathology, University College London - Cancer Research UK Lung Cancer Centre of Excellence, Independent, The Francis Crick Institute, University College London - Division of Infection and Immunity, Royal Marsden NHS Foundation Trust - Renal and Skin Units, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, University College London - Cancer Immunology Unit, The Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory and Independent
Downloads 67 (899,324)
Citation 1

Abstract:

Loading...

clear cell renal cell carcinoma, nivolumab, immunotherapy, cytotoxicity, TCR clonal maintenance, TCR clonal replacement, human endogenous retrovirus, longitudinal sampling, multiregion sampling, autopsy

2.

Real-World Outcomes with Ipilimumab and Nivolumab in Advanced Melanoma: A Multicentre Retrospective Study

Number of pages: 20 Posted: 31 Mar 2022
Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, The University of Sydney - Melanoma Institute Australia, affiliation not provided to SSRN, The University of Manchester, The Christie NHS Foundation Trust, Blacktown Hospital, The University of Sydney - Melanoma Institute Australia, Hospital of Barcelona, Vanderbilt University - Vanderbilt-Ingram Cancer Center, The University of Sydney - Melanoma Institute Australia, Royal Marsden NHS Foundation Trust - Renal and Skin Units, NHS Foundation Trust - Royal Marsden Hospital, Netherlands Cancer Institute and The University of Manchester
Downloads 43 (1,145,425)

Abstract:

Loading...

melanoma, real-world, ipilimumab+nivolumab, immunotherapy